TG Therapeutics Announces Positive Outcome from UNITY-NHL Phase 2b Pivotal Trial Evaluating Umbralisib in Patients with Relapsed/Refractory Marginal Zone Lymphoma
USA Life Sciences Database,
Study met the primary endpoint of Overall Response Rate (ORR) Interim data to be presented in an oral presentation at the 2019…